CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Research and development	$ 21,915	$ 15,280
General and administrative	8,507	7,520
Total operating expenses	30,422	22,800
Loss from operations	(30,422)	(22,800)
Other income:
Interest income	1,989	63
Total other income	1,989	63
Net loss	$ (28,433)	$ (22,737)
Net loss per share attributable to common stockholders, basic	$ (0.43)	$ (0.61)
Net loss per share attributable to common stockholders, diluted	$ (0.43)	$ (0.61)
Weighted-average number of common shares outstanding, basic	66,265,703	37,293,438
Weighted-average number of common shares outstanding, diluted	66,265,703	37,293,438
Other comprehensive income (loss):
Unrealized gain (loss) on available for sale investments	$ 596	$ (1,072)
Total other comprehensive income (loss)	596	(1,072)
Comprehensive loss	$ (27,837)	$ (23,809)